Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GSK1265744

Known as: GSK744 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND Cabotegravir (GSK1265744) is an HIV-1 integrase strand transfer inhibitor with potent antiviral activity and a long… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Highly Cited
2015
Highly Cited
2015
BACKGROUND In phase 1 trials, the HIV-1 integrase strand transfer inhibitor cabotegravir (GSK1265744) was well tolerated, both… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2014
Highly Cited
2014
Background:GSK1265744 (744) is an HIV-1 integrase inhibitor in clinical development as a long-acting (LA) injectable formulation… Expand
Highly Cited
2014
Highly Cited
2014
Objective:Pharmacokinetics, safety, and tolerability of GSK1265744 (744) and rilpivirine (RPV) (TMC278) were assessed after… Expand
Highly Cited
2014
Highly Cited
2014
ABSTRACT GSK1265744 is a new HIV integrase strand transfer inhibitor (INSTI) engineered to deliver efficient antiviral activity… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2014
2014
  • E. Dolgin
  • Nature Medicine
  • 2014
  • Corpus ID: 205378175
BOSTON — The results from a particular drug trial presented here last month at the annual Conference on Retroviruses and… Expand
Highly Cited
2014
Highly Cited
2014
Keeping HIV at Bay? Preexposure prophylaxis involving daily doses of drugs can, with variable success rates, interrupt HIV… Expand
Highly Cited
2013
Highly Cited
2013
Abstract Background: GSK1265744 is an HIV integrase strand transfer inhibitor selected for clinical development. Objective: This… Expand
Highly Cited
2013
Highly Cited
2013
We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1) integrase inhibitors dolutegravir (S/GSK1349572… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Highly Cited
2013
Highly Cited
2013
ABSTRACT Dolutegravir (DTG) and GSK1265744 are HIV integrase inhibitors (INIs) in clinical development. The oral formulation of… Expand
  • table 1
  • table 3
  • figure 1
  • figure 2
  • figure 3